Senate Bill 297 aims to protect registered professional nurses by ensuring their refusal to work beyond their predetermined schedule is not grounds for administrative action. It also establishes penalties for hospitals that violate rules related to mandatory overtime for nurses, as referenced in section 21526. Hospitals found in violation could face an administrative fine of $1,000 for each instance, along with other potential sanctions. This bill amends the Public Health Code to implement these provisions, directly affecting nurses and hospitals.
Senate Bill 296 prohibits hospitals from requiring registered professional nurses to work beyond their regularly scheduled, on-call, or voluntarily agreed-upon hours. It mandates that nurses working 12 or more consecutive hours receive 8 consecutive hours of off-duty time immediately afterward. Exceptions to this prohibition include declared states of emergency, mass casualty incidents, certain patient-care procedures, and situations where an oncoming nurse is unexpectedly absent. The bill also protects nurses from retaliation if they refuse work assignments that exceed these limits and requires hospitals to post notices informing nurses of these provisions.
SB 398 modifies requirements for substance use disorder treatment programs in Michigan and prohibits state agencies from creating new rules about these services. It directly affects treatment providers and the state health department (DHHS) by changing existing standards for program operations and blocking future rulemaking on specific service requirements. Key provisions include updating program eligibility rules under MCL 333.6230 and banning the development of new rules under MCL 333.6234. The bill aims to streamline program standards while preventing additional regulatory burdens on treatment providers.
Senate Bill 136 primarily eliminates the requirement for healthcare providers to notify patients about dense breast tissue after mammography. This change directly impacts patients undergoing mammograms and the medical facilities that perform these screenings in Michigan. The bill also enacts broader amendments concerning the use of radiation machines for mammography procedures. These modifications are made by amending and repealing specific sections within the existing Public Health Code.
SB 399 amends Michigan's definition of "drug paraphernalia" in the Public Health Code to explicitly exclude certain testing products, like fentanyl test strips, from being classified as paraphernalia. The bill states that tools used to detect harmful chemicals in controlled substances - such as strips for testing fentanyl - do not count as drug paraphernalia under state law. This change directly affects individuals using these testing products for safety, including people who use or distribute them to prevent overdoses. The amendment aims to remove legal barriers for harm-reduction tools without altering other provisions about paraphernalia.
SB 405 amends Michigan's "Administration of Opioid Antagonists Act" by revising the definition of "governmental agency" to explicitly exclude school district boards, public school academies, and licensed healthcare providers (under Public Health Code Part 209). This change means these entities will no longer be subject to the act's requirements regarding opioid antagonist access and training. The bill directly affects school districts, public school academies, and licensed healthcare facilities by removing them from the scope of the law. The amendment clarifies which organizations must comply with the act's provisions, focusing on state and local government entities rather than schools or healthcare providers. This is a technical definitional update with no new requirements or funding changes.
SB 154 makes it a crime to obstruct access to healthcare facilities, such as clinics or hospitals. It directly affects individuals who block entrances, interfere with patients or staff, or prevent access to medical services. The bill creates new criminal penalties for these actions under a newly established legal section. This law applies broadly to all healthcare facilities providing medical services, without specifying particular types of care.
SB 155 amends sentencing guidelines to address crimes specifically targeting access to healthcare facilities, such as blocking entrances or threatening staff. It would establish new sentencing standards for these offenses under Michigan's criminal code (MCL 777.13n). The bill directly affects individuals convicted of obstructing healthcare access, potentially altering their prison terms or penalties. However, the provided context does not detail the exact sentencing changes or specific crime definitions. This summary is based solely on the bill's title and official reference, without additional policy specifics.
SB 180 is a funding bill that allocates $39.29 billion to Michigan's Department of Health and Human Services (DHHS) for the 2025-2026 fiscal year. It provides specific funding for key programs including $276 million for department administration and management, $195 million for child support enforcement operations, and $197 million for community services like homeless programs, diaper assistance, and housing support. The bill directly affects DHHS operations and the state's recipients of these services, such as families using child support enforcement, homeless individuals accessing shelter programs, and low-income households receiving food or housing aid. It establishes the financial framework for these programs but does not change their underlying policies or eligibility rules.
SB 3 creates a Prescription Drug Affordability Board to establish maximum payment limits for certain prescription drugs, including brand-name, generic, biologic, and biosimilar medications. The Board, appointed by the governor with health care expertise, will review drug costs and set these limits to improve affordability for Michigan residents. It also establishes a Prescription Drug Affordability Stakeholder Council to provide input and a fund to support the program. This law directly affects drug manufacturers, health insurers, pharmacy benefit managers, and state agencies by requiring adherence to the set payment limits.
